- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Jakafi ®
Total 20146 results
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI)RecruitingSmoldering Plasma Cell MyelomaUnited States
-
University Clinical Centre of KosovaUniversity of Ljubljana, Faculty of MedicineUnknownType 2 Diabetes Mellitus | PeriodontitisKosovo
-
Emory UniversityNational Cancer Institute (NCI)RecruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
AmgenInnovative Therapies For Children with Cancer Consortium; Therapeutic Advances...Active, not recruitingAcute Lymphoblastic Leukemia (ALL)Spain, United Kingdom, United States, Korea, Republic of, Czechia, France, Russian Federation, Saudi Arabia, Thailand, Canada, Italy, Singapore, Turkey, Taiwan, Portugal, Poland, Romania, Brazil, Australia, Greece, Argentina, Mexico, Austr... and more
-
St. Jude Children's Research HospitalTerminatedAcute Myeloid Leukemia | Acute Lymphoid Leukemia | Mixed Lineage Acute LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedLymphoma | LeukemiaUnited States
-
Astellas Pharma Global Development, Inc.Completed
-
National Institute of Mental Health (NIMH)CompletedSchizophreniaUnited States
-
St. Jude Children's Research HospitalPfizerRecruitingAcute Lymphoblastic LeukemiaUnited States
-
National Human Genome Research Institute (NHGRI)TerminatedPulmonary Fibrosis | Metabolic Disease | Oculocutaneous Albinism | Hermansky-Pudlak Syndrome (HPS) | Platelet Storage Pool DeficiencyUnited States
-
SanofiActive, not recruitingPlasma Cell Myeloma RecurrentTaiwan, Brazil, Greece, Japan, Turkey, Czechia, France, Norway, Chile, Spain, United Kingdom, Argentina, United States, Australia, Canada, China, Germany, Hungary, Italy, Poland, Sweden
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKlineRecruitingPlasma Cell MyelomaUnited States
-
University of California, San FranciscoJanssen Pharmaceuticals; Multiple Myeloma Research FoundationTerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Plasma Cell MyelomaUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI); Janssen Scientific Affairs, LLCWithdrawnRecurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 | Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22)... and other conditionsUnited States
-
Organon and CoCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedColorectal Cancer | Nausea and VomitingUnited States
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET Myelofibrosis | MFUnited States
-
M.D. Anderson Cancer CenterActive Biotech ABNot yet recruitingPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-Essential Thrombocytosis MyelofibrosisUnited States
-
University of ChicagoNot yet recruitingMyeloproliferative NeoplasmsUnited States
-
OncotherapeuticsIncyte CorporationNot yet recruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Washington University School of MedicineIncyte CorporationRecruitingGraft Versus Host Disease | Graft Vs Host Disease | Graft-versus-host-diseaseUnited States
-
Baylor Research InstituteNot yet recruitingBreast Cancer | Metastatic Triple-Negative Breast CarcinomaUnited States
-
Karyopharm Therapeutics IncRecruitingMyelofibrosis | Moderate ThrombocytopeniaUnited States
-
Incyte CorporationRecruitingMyeloproliferative NeoplasmsSpain, Japan, France, Italy, Germany, Australia, United Kingdom, Denmark, Canada
-
Medical College of WisconsinRecruitingGraft-versus-host DiseaseUnited States
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
Telios Pharma, Inc.RecruitingPrimary Myelofibrosis | Myelofibrosis | Post-PV MF | Post-ET MyelofibrosisSpain, United States, France, Poland, Italy, Germany
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid Cell Neoplasm | Steroid Refractory Graft Versus Host DiseaseUnited States
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States
-
Kartos Therapeutics, Inc.RecruitingMyelofibrosisUnited States, France, Australia, Spain, Germany, Bulgaria, Israel, Italy, Poland
-
National Cancer Centre, SingaporeRecruitingColorectal Cancer | Pancreatic AdenocarcinomaSingapore
-
University of WashingtonRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm | Secondary Myelofibrosis | Myeloproliferative Neoplasm, UnclassifiableUnited States
-
Ohio State University Comprehensive Cancer CenterIncyte Corporation; Jazz PharmaceuticalsRecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Secondary Acute Myeloid Leukemia | Myeloproliferative NeoplasmUnited States
-
Veronika BachanovaBristol-Myers Squibb; Incyte CorporationRecruitingHodgkin LymphomaUnited States
-
University of ChicagoIncyte CorporationRecruitingAcute Lymphoblastic Leukemia | ALL, Childhood | ALLUnited States
-
Massachusetts General HospitalWashington University School of Medicine; Medical College of Wisconsin; Vanderbilt... and other collaboratorsRecruitingAcute Myeloid Leukemia | Allogeneic Stem Cell Transplantation | Acute Myeloid Leukemia in RemissionUnited States
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrimary Myelofibrosis | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Myelofibrosis Transformation in Essential ThrombocythemiaUnited States
-
Vanderbilt-Ingram Cancer CenterCompletedPolycythemia Vera | MyelofibrosisUnited States
-
AbbVieActive, not recruitingMyelofibrosis (MF)United States, Australia, Canada, Croatia, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Puerto Rico, Spain, United Kingdom, Taiwan